ICG buys Dutch life science R&D facility as part of €1b investment drive

Intermediate Capital Group (ICG) has acquired Syngenta’s seeds research & development and production facility in Enkhuizen, Netherlands, by way of a 20 year triple-net sale & leaseback. Financial details were kept confidential

Would you like to read more? Log in first (top right of the screen) or take a trial.

Events

Latest news

Best read stories